Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immunovant, Inc. | Chief Legal Officer | Common Stock | 319K | $8.12M | $25.45 | Nov 20, 2024 | Direct |
Immunovant, Inc. | Chief Legal Officer | Stock Option (right to buy) | 68.7K | Apr 2, 2024 | Direct | ||
Flexion Therapeutics Inc | General Counsel | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | General Counsel | Stock Option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMVT | Immunovant, Inc. | Nov 20, 2024 | 1 | -$92.9K | 4 | Nov 22, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Oct 23, 2024 | 1 | -$129K | 4 | Oct 25, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Oct 16, 2024 | 1 | -$82.3K | 4 | Oct 18, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Aug 21, 2024 | 2 | -$105K | 4 | Aug 23, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jul 24, 2024 | 1 | -$111K | 4 | Jul 26, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jul 17, 2024 | 2 | -$74.4K | 4 | Jul 19, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | May 22, 2024 | 1 | -$96.1K | 4 | May 24, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Apr 24, 2024 | 1 | -$115K | 4 | Apr 26, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Apr 17, 2024 | 2 | -$286K | 4 | Apr 19, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Apr 2, 2024 | 2 | $0 | 4 | Apr 4, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Feb 22, 2024 | 1 | -$77.1K | 4 | Feb 23, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jan 26, 2024 | 2 | -$115K | 4 | Jan 29, 2024 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Nov 22, 2023 | 2 | -$107K | 4 | Nov 24, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Oct 25, 2023 | 1 | -$142K | 4 | Oct 27, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Aug 24, 2023 | 2 | -$249K | 4 | Aug 25, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jul 26, 2023 | 1 | -$84.7K | 4 | Jul 27, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Apr 25, 2023 | 1 | -$42.9K | 4 | Apr 26, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jan 26, 2023 | 1 | -$188K | 4 | Jan 27, 2023 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Aug 17, 2022 | 2 | $0 | 4 | Aug 19, 2022 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jan 28, 2022 | 2 | $0 | 4 | Jan 31, 2022 | Chief Legal Officer |
IMVT | Immunovant, Inc. | Jan 19, 2022 | 0 | $0 | 3 | Jan 28, 2022 | Chief Legal Officer |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 6 | -$1.13M | 4 | Nov 19, 2021 | General Counsel |
FLXN | Flexion Therapeutics Inc | Jul 19, 2021 | 1 | -$25.4K | 4 | Jul 20, 2021 | General Counsel |